Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INI101 vs BOTOX® in Moderate to Severe Glabellar Lines
NCT07622004Phase 3Completed
- Sponsor
- Inibio
- Start
- May 2021
- Primary completion
- Jan 2022
- Countries
- 1
01
Overview
A Phase 3 trial of INI101 in glabellar lines, sponsored by Inibio. Started May 2021; status: completed.
02
Drugs
INI101
03
Conditions
glabellar lines
Beyond the preview
Go deeper on NCT07622004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07622004.